Skip to main content
. 2021 Mar 17;156(5):444–451. doi: 10.1001/jamasurg.2021.0133

Table 2. Data on Morbidity and Mortality.

Morbidity type or mortality Patients, No. (%) Between-group difference, RD (95% CI)a P value
nCRT group (n = 114) nCT group (n = 108)
All complications 54 (47.4) 46 (42.6) 4.8 (–8.2 to 17.5) .48
Pneumonia 17 (14.9) 14 (13.0) 1.9 (–7.4 to 11.2) .68
ARDS 3 (2.6) 2 (1.9) 0.8 (–7.4 to 11.2) .95
Pneumothorax 2 (1.8) 1 (0.9) 0.8 (–4.2 to 5.8) .96
Arrhythmia 5 (4.4) 3 (2.8) 1.6 (–4.1 to 7.4) .78
Anastomotic leak 11 (9.6) 12 (11.1) –1.5 (–6.8 to 9.9) .72
Gastrointestinal bleeding 1 (0.9) 1 (0.9) 0 (–4.0 to 4.2) .50
Liver function damage 2 (1.8) 0 1.8 (–1.7 to 6.5) .50
Recurrent nerve injury 6 (5.3) 7 (6.5) –1.2 (–5.4 to 8.1) .70
Acute delirium 0 1 (0.9) –0.9 (–2.4 to 5.1) .98
Intrathoracic abscess 1 (0.9) 1 (0.9) 0 (–4.0 to 4.2) .50
Wound infection 1 (0.9) 0 0.9 (–2.6 to 4.8) .98
Generalized sepsis 1 (0.9) 0 0.9 (–2.6 to 4.8) .98
Chylothorax 3 (2.6) 3 (2.8) –0.1 (–5.0 to 5.5) .73
Acute diaphragmatic hernia 1 (0.9) 0 0.9 (–2.6 to 4.8) .98
Stroke (CVA) 0 1 (0.9) –0.9 (–2.4 to 5.1) .98
Clavien-Dindo grade
I 27 (23.7) 25 (23.1) 0.5 (–10.6 to 11.6) .93
II 5 (4.4) 3 (2.8) 1.6 (–4.1 to 7.4) .78
IIIa 9 (7.9) 6 (5.6) 2.3 (–4.7 to 9.4) .49
IIIb 8 (7.0) 9 (8.3) –1.3 (–6.0 to 8.9) .71
IVa 2 (1.8) 1 (0.9) 0.8 (–3.5 to 5.3) .96
IVb 0 0 0 >.99
V 3 (2.6) 1 (0.9) 1.7 (–2.8 to 6.6) .65
Clavien-Dindo grade IIIb or higher 13 (11.4) 11 (10.2) 1.2 (–7.3 to 9.6) .77
90-d Postoperative mortality 4 (3.5) 3 (2.8) 0.7 (–4.8 to 6.2) .94

Abbreviations: ARDS, acute respiratory distress syndrome; CVA, cerebrovascular accident; nCRT, neoadjuvant chemoradiotherapy; nCT, neoadjuvant chemotherapy; RD, rate difference.

a

Calculated using the Newcombe method.22